Surgical procedures exist and are effective for patients with resectable and borderline resectable pancreatic tumors. The clinical issue is introduced when patients have metastatic disease because surgery becomes more difficult and often chemotherapy or radiation therapy is needed. Modern advances in care have also brought targeted therapies into the landscape, but there remains in gap in efficacy compared with other gastrointestinal cancers. Read more . . .